Identification of a de novo mutation in ANO5 by whole exome sequencing and clinical phenotype of familial gigantiform cementoma

doi:10.19438/j.cjoms.2022.04.008

Abstract

Abstract: PURPOSE: To develop an approach based on whole exome sequencing (WES) to explore the correlation between genotype and clinical phenotype of a Chinese familial gigantiform cementoma (FGC) family caused by a mutation in ANO5 gene. METHODS: Nine patients from a Chinese FGC family with facial deformities and lower limb fractures were included. The clinical manifestations, skeletal radiographic features, bone mineral density (BMD), and bone turnover biomarkers were investigated. Peripheral blood from 9 patients and 14 controls within the family was collected, and WES was performed. By using filtering strategy, the candidate genes were sequenced and further validated by PCR and Sanger sequencing in the unaffected individuals within the family and 384 healthy control subjects. RESULTS: The major manifestations of Chinese FGC patients were representative multiquadrant and expansive deformities involving the mandible and maxilla, especially severe in the anterior mandible with diffuse osteopenia bone loss and several fractures in the lower limbs. Sequencing results showed that there was a missense, heterozygous mutation in ANO5 (c.1538C>T, p.Thr513Ile) in all affected individuals, that affected the folding, structure and function of ANO5. CONCLUSIONS: FGC is a rare autosomal dominant hereditary disease caused by ANO5 mutations, with severe facial deformity, long bone fractures and low BMD as main characteristics of Chinese' patients. The first and a novel missense mutation of ANO5 was identified, which extended the phenotypic and genetic spectrum of FGC.

Key words: Familial gigantiform cementoma, ANO5 gene, Novel mutation, Phenotype, Genotype

CLC Number:

R739.8

LI Xin, WANG Zhou-yang, QIN Xing-jun. Identification of a de novo mutation in ANO5 by whole exome sequencing and clinical phenotype of familial gigantiform cementoma[J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(4): 360-365.

References

[1] Moshref M, Khojasteh A, Kazemi B, et al.Autosomal dominant gigantiform cementoma associated with bone fractures[J]. Am J Med Genet A, 2008, 146A(5): 644-648.
[2] Agazzi C, Belloni L.Hard odontomas of the jaws. Clinico-roentgenologic and anatomo-microscopic contribution with special reference to widely extensive forms with familial occurrence[J]. Arch Ital Otol Rinol Laringol, 1953, 64(Suppl 16): 1-103.
[3] Wang HW, Yu M, Qin XJ, et al.Familial gigantiform cementoma: distinctive clinical features of a large Chinese pedigree[J]. Br J Oral Maxillofac Surg, 2015, 53(1): 83-85.
[4] Finical SJ, Kane WJ, Clay RP, et al.Familial gigantiform cementoma[J]. Plast Reconstr Surg, 1999, 103(3): 949-954.
[5] Rossbach HC, Letson D, Lacson A, et al.Familial gigantiform cementoma with brittle bone disease, pathologic fractures, and osteosarcoma: a possible explanation of an ancient mystery[J]. Pediatr Blood Cancer, 2005, 44(4): 390-396.
[6] Wang HW, Ma CY, Qin XJ, et al.Management strategy in patient with familial gigantiform cementoma: a case report and analysis of the literature[J]. Medicine (Baltimore), 2017, 96(50): e9138.
[7] Hicks D, Sarkozy A, Muelas N, et al.A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophy[J]. Brain, 2011, 134(Pt 1): 171-182.
[8] Bolduc V, Marlow G, Boycott KM, et al.Recessive mutations in the putative calcium-activated chloride channel anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies[J]. Am J Hum Genetics, 2010, 86(2): 213-221.
[9] Penttilä S, Palmio J, Suominen T, et al.Eight new mutations and the expanding phenotype variability in muscular dystrophy caused by ANO5[J]. Neurology, 2012, 78(12): 897-903.
[10] Wang X, Liu X, Dong R, et al.Genetic disruption of anoctamin 5 in mice replicates human gnathodiaphyseal dysplasia (GDD)[J]. Calcified Tissue Int, 2019, 104(6): 679-689.
[11] Rolvien T, Avci O, von Kroge S, et al. Gnathodiaphyseal dysplasia is not recapitulated in a respective mouse model carrying a mutation of the Ano5 gene[J]. Bone Rep, 2020, 12: 100281.
[12] Pedemonte N, Galietta LJV.Structure and function of TMEM16 proteins (anoctamins)[J]. Physiol Rev, 2014, 94(2): 419-459.
[13] Dang S, Feng S, Tien J, et al.Cryo-EM structures of the TMEM16A calcium-activated chloride channel[J]. Nature, 2017, 552(7685): 426-429.
[14] Paulino C, Kalienkova V, Lam AKM, et al.Activation mechanism of the calcium-activated chloride channel TMEM16A revealed by cryo-EM[J]. Nature, 2017, 552(7685): 421-425.
[15] Brunner JD, Lim NK, Schenck S, et al.X-ray structure of a calcium-activated TMEM16 lipid scramblase[J]. Nature, 2014, 516(7530): 207-212.
[16] Marconi C, Binello PB, Badiali G, et al.A novel missense mutation in ANO5/TMEM16E is causative for gnathodiaphyseal dyplasia in a large Italian pedigree[J]. Eur J Hum Genet, 2013, 21(6): 613-619.
[17] Andreeva TV, Tyazhelova TV, Rykalina VN, et al.Whole exome sequencing links dental tumor to an autosomal-dominant mutation in ANO5 gene associated with gnathodiaphyseal dysplasia and muscle dystrophies[J]. Sci Rep, 2016, 6: 26440.
[18] Tsutsumi S, Kamata N, Vokes TJ, et al.The novel gene encoding a putative transmembrane protein is mutated in gnathodiaphyseal dysplasia (GDD)[J]. Am J Hum Genetics, 2004, 74(6): 1255-1261.
[19] Jin L, Liu Y, Sun F, et al.Three novel ANO5 missense mutations in Caucasian and Chinese families and sporadic cases with gnathodiaphyseal dysplasia[J]. Sci Rep, 2017, 7: 40935.
[20] Otaify GA, Whyte MP, Gottesman GS, et al.Gnathodiaphyseal dysplasia: severe atypical presentation with novel heterozygous mutation of the anoctamin gene(ANO5)[J]. Bone, 2018, 107: 161-171.